▁company ▁acquired ▁Pat he on , ▁a ▁contract ▁development ▁and ▁manufact uring ▁organization ▁serving ▁the ▁ph arma ce ut ical ▁and ▁bi ote chn ology ▁se ctors , ▁for ▁approximately ▁$ 7 . 2 ▁billion . ▁As ▁of ▁ 2 0 1 7 , ▁the ▁company ▁had ▁reven ues ▁of ▁$ 2 0 . 9 ▁billion ▁and ▁was ▁a ▁Fort une ▁ 5 0 0 ▁company . ▁ ▁In ▁September ▁ 2 0 1 8 , ▁Th ermo ▁Fish er ▁Scient ific ▁announced ▁it ▁had ▁signed ▁a ▁definit ive ▁agreement ▁with ▁B ect on , ▁Dick inson ▁and ▁Company ▁( BD ) ▁to ▁ac quire ▁their ▁Advanced ▁Bi opro cess ing ▁business . ▁ ▁TH is ▁B D ▁business ▁had ▁annual ized ▁re venue ▁of ▁approximately ▁$ 1 0 0 ▁million ; ▁as ▁of ▁October ▁ 1 6 , ▁ 2 0 1 8 , ▁it ▁had ▁been ▁integrated ▁into ▁Th ermo ▁Fish er ' s ▁Life ▁Sciences ▁Sol utions ▁Seg ment . ▁ ▁In ▁March ▁ 2 0 1 9 , ▁Th ermo ▁Fish er ▁announced ▁its ▁entry ▁into ▁the ▁gene ▁ther apy ▁manufact uring ▁market ▁with ▁a ▁$ 1 . 7 ▁billion ▁c ash ▁ac quisition ▁for ▁Br ammer ▁Bio . ▁In ▁May ▁ 2 0 1 9 , ▁Th ermo ▁Fish er ▁partner ed ▁with ▁MM J ▁International ▁Hold ings ▁to ▁manufact ure ▁drug ▁products ▁developed ▁by ▁MM J ▁for ▁the ▁treatment ▁of ▁Multiple ▁S cl eros is ▁and ▁Hun ting ton ' s ▁D ise ase . ▁In ▁June